Literature DB >> 20592493

New insights into cathepsin D in mammary tissue development and remodeling.

Naira V Margaryan1, Dawn A Kirschmann, Alina Lipavsky, Caleb M Bailey, Mary J C Hendrix, Zhila Khalkhali-Ellis.   

Abstract

Cathepsin D (CatD) is a lysosomal aspartyl endopeptidase originally considered a "house keeping enzyme" involved in the clearance of unwanted proteins. However, recent studies have revealed CatD's involvement in apoptosis and autophagy, thus signifying an important function in the proper development and maintenance of multi-cellular organs. In the mammary gland, matrix degradation and the remodeling process are orchestrated by proteolytic enzymes, but the role of CatD at distinct developmental stages has remained mostly unexplored. Based on our previous studies we sought to address the role of this endopeptidase in mammary gland development and remodeling. By employing a mouse model, we report a previously unidentified participation of CatD in different stages of mammary gland development. Our findings reveal that CatD undergoes distinct protein processing at different stages of mammary gland development, and this customized processing results in differential enzymatic activity (constitutive and low pH activatable) best fitting particular stage(s) of development. In addition, at the onset of involution the N-glycan structure of this endopeptidase switches from a mixed high mannose and hybrid structure to an almost exclusively high mannose type, but reverts back to the original N-glycan composition by day 4 of involution. Our findings illuminate (at least in part) the "raison d'être" for CatD's numerous and highly regulated proteolytic processing steps from the pro-form to the mature enzyme. In the mammary gland, specific cleavage product(s) perform specialized function(s) befitting each stage of remodeling. It is noteworthy that deregulated synthesis, secretion and glycosylation of CatD are hallmarks of cancer progression. Thus, identifying the role of CatD in a dynamic normal tissue undergoing highly regulated cycles of remodeling could provide valuable information illuminating the deregulation of CatD associated with cancer development and metastasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20592493      PMCID: PMC3040969          DOI: 10.4161/cbt.10.5.12534

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  34 in total

1.  Biosynthesis of lysosomal enzymes in fibroblasts. Phosphorylation of mannose residues.

Authors:  A Hasilik; E F Neufeld
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

2.  Progesterone-mediated inhibition of casein mRNA and polysomal casein synthesis in the rat mammary gland during pregnancy.

Authors:  J M Rosen; D L O'Neal; J E McHugh; J P Comstock
Journal:  Biochemistry       Date:  1978-01-24       Impact factor: 3.162

3.  Mice lacking N-acetylglucosaminyltransferase I activity die at mid-gestation, revealing an essential role for complex or hybrid N-linked carbohydrates.

Authors:  E Ioffe; P Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

4.  Cathepsin L is involved in cathepsin D processing and regulation of apoptosis in A549 human lung epithelial cells.

Authors:  Aline Wille; Annegret Gerber; Anke Heimburg; Anita Reisenauer; Christoph Peters; Paul Saftig; Thomas Reinheckel; Tobias Welte; Frank Bühling
Journal:  Biol Chem       Date:  2004-07       Impact factor: 3.915

5.  Apoptosis in lactating and involuting mouse mammary tissue demonstrated by nick-end DNA labelling.

Authors:  L H Quarrie; C V Addey; C J Wilde
Journal:  Cell Tissue Res       Date:  1995-09       Impact factor: 5.249

6.  Lysosomal enzyme phosphorylation. II. Protein recognition determinants in either lobe of procathepsin D are sufficient for phosphorylation of both the amino and carboxyl lobe oligosaccharides.

Authors:  A B Cantor; T J Baranski; S Kornfeld
Journal:  J Biol Chem       Date:  1992-11-15       Impact factor: 5.157

7.  Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis.

Authors:  Nicolas Bidère; Hans K Lorenzo; Sylvie Carmona; Mireille Laforge; Francis Harper; Céline Dumont; Anna Senik
Journal:  J Biol Chem       Date:  2003-06-02       Impact factor: 5.157

8.  Apoptosis and involution in the mammary gland are altered in mice lacking a novel receptor, beta1,4-Galactosyltransferase I.

Authors:  Laura de la Cruz; Kristin Steffgen; Andrea Martin; Carli McGee; Helen Hathaway
Journal:  Dev Biol       Date:  2004-08-15       Impact factor: 3.582

9.  Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells.

Authors:  P Saftig; M Hetman; W Schmahl; K Weber; L Heine; H Mossmann; A Köster; B Hess; M Evers; K von Figura
Journal:  EMBO J       Date:  1995-08-01       Impact factor: 11.598

10.  Complex asparagine-linked oligosaccharides are required for morphogenic events during post-implantation development.

Authors:  M Metzler; A Gertz; M Sarkar; H Schachter; J W Schrader; J D Marth
Journal:  EMBO J       Date:  1994-05-01       Impact factor: 11.598

View more
  11 in total

1.  Cathepsin D: Regulation in mammary gland remodeling, misregulation in breast cancer.

Authors:  Evette S Radisky
Journal:  Cancer Biol Ther       Date:  2010-09-30       Impact factor: 4.742

2.  Enzymatically active cathepsin D sensitizes breast carcinoma cells to TRAIL.

Authors:  Blanka Jancekova; Eva Ondrouskova; Lucia Knopfova; Jan Smarda; Petr Benes
Journal:  Tumour Biol       Date:  2016-02-11

Review 3.  A Phenomic Perspective on Factors Influencing Breast Cancer Treatment: Integrating Aging and Lifestyle in Blood and Tissue Biomarker Profiling.

Authors:  Ainhoa Arana Echarri; Mark Beresford; John P Campbell; Robert H Jones; Rachel Butler; Kenneth J Gollob; Patricia C Brum; Dylan Thompson; James E Turner
Journal:  Front Immunol       Date:  2021-02-01       Impact factor: 7.561

4.  Rutin Supplementation Reduces Oxidative Stress, Inflammation and Apoptosis of Mammary Gland in Sheep During the Transition Period.

Authors:  Hongyan Ding; Yu Li; Chang Zhao; Yue Yang; Chengkun Xiong; Daoliang Zhang; Shibin Feng; Jinjie Wu; Xichun Wang
Journal:  Front Vet Sci       Date:  2022-05-27

5.  Knock-down of cathepsin D affects the retinal pigment epithelium, impairs swim-bladder ontogenesis and causes premature death in zebrafish.

Authors:  Carlo Follo; Matteo Ozzano; Vera Mugoni; Roberta Castino; Massimo Santoro; Ciro Isidoro
Journal:  PLoS One       Date:  2011-07-01       Impact factor: 3.240

6.  Two Faces of Cathepsin D: Physiological Guardian Angel and Pathological Demon.

Authors:  Zhila Khalkhali-Ellis; Mary J C Hendrix
Journal:  Biol Med (Aligarh)       Date:  2014-07

7.  Cathepsin D protects colorectal cancer cells from acetate-induced apoptosis through autophagy-independent degradation of damaged mitochondria.

Authors:  C S F Oliveira; H Pereira; S Alves; L Castro; F Baltazar; S R Chaves; A Preto; M Côrte-Real
Journal:  Cell Death Dis       Date:  2015-06-18       Impact factor: 8.469

8.  The Plasma Proteome Is Associated with Anthropometric Status of Undernourished Nepalese School-Aged Children.

Authors:  Sun Eun Lee; Christine P Stewart; Kerry J Schulze; Robert N Cole; Lee S-F Wu; James D Yager; John D Groopman; Subarna K Khatry; Ramesh Kant Adhikari; Parul Christian; Keith P West
Journal:  J Nutr       Date:  2017-02-01       Impact factor: 4.798

9.  Stat3 controls cell death during mammary gland involution by regulating uptake of milk fat globules and lysosomal membrane permeabilization.

Authors:  Timothy J Sargeant; Bethan Lloyd-Lewis; Henrike K Resemann; Antonio Ramos-Montoya; Jeremy Skepper; Christine J Watson
Journal:  Nat Cell Biol       Date:  2014-10-05       Impact factor: 28.824

10.  Cleavage of Histone 3 by Cathepsin D in the involuting mammary gland.

Authors:  Zhila Khalkhali-Ellis; William Goossens; Naira V Margaryan; Mary J C Hendrix
Journal:  PLoS One       Date:  2014-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.